All Stories

  1. Quasispecies Changes with Distinctive Point Mutations in the Hepatitis C Virus Internal Ribosome Entry Site (IRES) Derived from PBMCs and Plasma

    Article • Advances in Virology, November 2018, Hindawi Publishing Corporation

    Professor Peter Karayiannis

  2. Editorial: HBsAg serum levels in HBeAg-negative chronic HBV infection-is it a matter of genotype?

    Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

    Professor Peter Karayiannis

  3. The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection

    Article • Frontiers in Microbiology, January 2016, Frontiers

    Professor Peter Karayiannis

  4. Welcome to the new, all electronic Journal of Viral Hepatitis

    Article • Journal of Viral Hepatitis, December 2014, Wiley

    Professor Peter Karayiannis

  5. Treatment options beyond IFNαand NUCs for chronic HBV infection: expectations for tomorrow

    Article • Journal of Viral Hepatitis, October 2014, Wiley

    Professor Peter Karayiannis

  6. HCV NS5A co-operates with PKR in modulating HCV IRES-dependent translation

    Article • Infection Genetics and Evolution, August 2014, Elsevier

    Professor Peter Karayiannis

  7. Editorial

    Article • Journal of Viral Hepatitis, January 2014, Wiley

    Professor Peter Karayiannis

  8. Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus)

    Article • Virus Research, January 2014, Elsevier

    Professor Peter Karayiannis

  9. Molecular Variants of Hepatitis B Surface Antigen (HBsAg)

    Article • July 2013, Wiley

    Professor Peter Karayiannis

  10. Molecular Variants of the Precore, Core, and Core Promoter Regions of Hepatitis B Virus, and Their Clinical Significance

    Article • July 2013, Wiley

    Professor Peter Karayiannis

  11. The GB Viruses: An Update of Their Biology, Molecular Virology and Significance

    Article • April 2013, Wiley

    Professor Peter Karayiannis

  12. 339 THE EFFECT OF PRECORE AND BASAL CORE PROMOTER MUTATIONS OF HEPATITIS B VIRUS IN VIRAL REPLICATION CONTROL AND NKG2D ACTIVATION

    Article • Journal of Hepatology, April 2013, Elsevier

    Professor Peter Karayiannis

  13. The role of the molecular biology laboratory in the management of chronic hepatitis B and C

    Article • Thalassemia Reports, March 2013, PAGEPress Publications

    Professor Peter Karayiannis

  14. Oral conditions associated with Hepatitis C virus infection

    Article • Saudi Journal of Gastroenterology, January 2013, Medknow

    Professor Peter Karayiannis

  15. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, September 2012, Oxford University Press (OUP)

    Dr Seyed Reza Mohebbi, Professor Peter Karayiannis

  16. Serum Hepatitis B Surface Antigen Levels and Their Utility as a Predictor of Sustained Virological Response After Antiviral Treatment

    Article • Hepatitis Monthly, July 2012, Kowsar Medical Institute

    Professor Peter Karayiannis

  17. Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

    Article • Scientifica, January 2012, Hindawi Publishing Corporation

    Professor Peter Karayiannis

  18. Oral fluid and hepatitis A, B and C: A literature review

    Article • Journal of Oral Pathology and Medicine, December 2011, Wiley

    Professor Peter Karayiannis

  19. Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B

    Article • Journal of Hepatology, July 2011, Elsevier

    Professor Peter Karayiannis

  20. Enterically Transmitted Viral Hepatitis: Hepatitis A and Hepatitis E

    Article • May 2011, Wiley

    Professor Peter Karayiannis

  21. Chapter-01 Hepatitis B Virus: General Features and Molecular Biology

    Article • January 2011, Jaypee Brothers Medical Publishing

    Professor Peter Karayiannis

  22. Dynamic Coinfection with Multiple Viral Subtypes in Acute Hepatitis C

    Article • The Journal of Infectious Diseases, December 2010, Oxford University Press (OUP)

    Peter Ferenci, Professor Peter Karayiannis

  23. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men

    Article • Gut, December 2010, BMJ

    Professor Peter Karayiannis

  24. The Detection of Hepatitis Viruses

    Article • January 2010, Springer Science + Business Media

    Professor Peter Karayiannis

  25. Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth

    Article • Journal of Medical Virology, December 2009, Wiley

    Professor Peter Karayiannis

  26. Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma

    Article • Journal of Viral Hepatitis, October 2009, Wiley

    Professor Peter Karayiannis

  27. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV

    Article • AIDS, January 2009, Wolters Kluwer Health

    Professor Peter Karayiannis

  28. Diagnosing acute hepatitis C in HIV-infected patients: Nucleic acid testing compared with antibody and antigen–antibody detecting methods

    Article • Journal of Clinical Virology, January 2009, Elsevier

    Professor Peter Karayiannis

  29. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

    Article • Liver International, December 2008, Wiley

    Professor Peter Karayiannis

  30. Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values

    Article • Journal of Medical Virology, November 2008, Wiley

    Professor Peter Karayiannis

  31. Systematic review: hepatic fibrosis - regression with therapy

    Article • Alimentary Pharmacology & Therapeutics, November 2008, Wiley

    Professor Peter Karayiannis

  32. Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study

    Article • Journal of Viral Hepatitis, September 2008, Wiley

    Professor Peter Karayiannis

  33. Restricted quasispecies variation following infection with the GB virus B

    Article • Virus Research, July 2008, Elsevier

    Professor Peter Karayiannis

  34. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication

    Article • Journal of General Virology, April 2008, Society for General Microbiology

    Professor Peter Karayiannis

  35. Hepatitis B Virus: General Features

    Article • January 2008, Elsevier

    Professor Peter Karayiannis

  36. 671 REACTIVATION OF HEPATITIS C IN A PATIENT WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS INFECTION

    Article • Journal of Hepatology, January 2008, Elsevier

    Professor Peter Karayiannis

  37. Editorial

    Article • Journal of Viral Hepatitis, December 2007, Wiley

    Professor Peter Karayiannis

  38. Replicative Competence of the T131I, K141E, and G145R Surface Variants of Hepatitis B Virus

    Article • The Journal of Infectious Diseases, October 2007, Oxford University Press (OUP)

    Professor Peter Karayiannis

  39. [404] REPLICATION EFFICIENCY OF HEPATITIS B VIRUS (HBV) INFECTIOUS CLONES BEARING CORE PROMOTER MUTATIONS IN A COMMON GENETIC BACKGROUND, AND PROMOTER ANALYSIS

    Article • Journal of Hepatology, April 2007, Elsevier

    Professor Peter Karayiannis

  40. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection

    Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

    Professor Peter Karayiannis

  41. Editorial

    Article • Journal of Viral Hepatitis, January 2007, Wiley

    Professor Peter Karayiannis

  42. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations

    Article • Journal of Viral Hepatitis, September 2006, Wiley

    Professor Peter Karayiannis

  43. Interferon-α therapy in HBeAg-negative chronic hepatitis B: a long-term prospective study from north-western Greece

    Article • Alimentary Pharmacology & Therapeutics, August 2006, Wiley

    Professor Peter Karayiannis

  44. 521 Clinical significance of anti-HBc as the only marker of hbv infection in general population. A cohort study with an observational period of up to 12 years

    Article • Journal of Hepatology, April 2006, Elsevier

    Professor Peter Karayiannis

  45. Established and Emerging Therapies for the Treatment of Viral Hepatitis

    Article • Digestive Diseases, January 2006, Karger Publishers

    Professor Peter Karayiannis

  46. Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine

    Article • Journal of Medical Virology, January 2006, Wiley

    Professor Peter Karayiannis

  47. Editorial

    Article • Journal of Viral Hepatitis, January 2006, Wiley

    Professor Peter Karayiannis

  48. O.169 Replication efficiency of hepatitis B virus infectious clones bearing core promoter, pre-core and surface gene mutations, in a common genetic background

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Peter Karayiannis

  49. P.180 Hepatitis C virus (HCV) internal ribosome entry site (IRES) variants from serum, liver and PBMCs and their translational efficiency in different cell lines

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Peter Karayiannis

  50. Heart Transplantation in Patients with Chronic Hepatitis B: Clinical Evolution, Molecular Analysis, and Effect of Treatment

    Article • Transplantation, November 2005, Wolters Kluwer Health

    Professor Peter Karayiannis

  51. The hepatitis C virus NS3/4A protease complex interferes with pathways of the innate immune response

    Article • Journal of Hepatology, October 2005, Elsevier

    Professor Peter Karayiannis

  52. Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?

    Article • Nature Clinical Practice Gastroenterology &#38 Hepatology, March 2005, Springer Science + Business Media

    Professor Peter Karayiannis

  53. Current therapies for chronic hepatitis B virus infection

    Article • Expert Review of Anti-infective Therapy, October 2004, Taylor & Francis

    Professor Peter Karayiannis

  54. Hepatitis vaccines

    Article • British Medical Bulletin, August 2004, Oxford University Press (OUP)

    Professor Peter Karayiannis

  55. Hepatitis B Surface Antigen Variant with Multiple Mutations in the a Determinant in an Agammaglobulinemic Patient

    Article • Journal of Clinical Microbiology, June 2004, ASM Journals

    Professor Peter Karayiannis

  56. Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

    Article • Journal of Virology, May 2004, ASM Journals

    Professor Peter Karayiannis

  57. ADJUVANT CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED BLADDER CANCER: A STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP

    Article • The Journal of Urology, April 2004, Elsevier

    Professor Peter Karayiannis

  58. Comparison of Hepatitis C Viral Loads in Patients with or without Coinfection with Different Genotypes

    Article • Clinical and Vaccine Immunology, March 2004, ASM Journals

    Professor Peter Karayiannis

  59. Editorial

    Article • Journal of Viral Hepatitis, January 2004, Wiley

    Professor Peter Karayiannis

  60. Effects of interferon on HCV and EMCV replication in the same cell line: Interferon inhibitory NS5A sequences do not inhibit the effects of IFN when expressed in the replicon

    Article • Journal of Hepatology, April 2003, Elsevier

    Professor Peter Karayiannis

  61. Hepatitis B virus: old, new and future approaches to antiviral treatment

    Article • Journal of Antimicrobial Chemotherapy, March 2003, Oxford University Press (OUP)

    Professor Peter Karayiannis

  62. Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-? preparations

    Article • Journal of Medical Virology, March 2003, Wiley

    Professor Peter Karayiannis

  63. An outbreak of HBV and HCV infection in a paediatric oncology ward: Epidemiological investigations and prevention of further spread

    Article • Journal of Medical Virology, January 2003, Wiley

    Professor Peter Karayiannis

  64. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects

    Article • Journal of Medical Virology, January 2003, Wiley

    Professor Peter Karayiannis

  65. Low HBeAg Serum Levels Correlate with the Presence of the Double A1762T/G1764A Core Promoter Mutation and a Positive Response to Interferon in Patients with Chronic Hepatitis B Virus Infection

    Article • Intervirology, January 2003, Karger Publishers

    Professor Peter Karayiannis

  66. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission

    Article • The American Journal of Gastroenterology, September 2002, Wolters Kluwer Health

    Professor Peter Karayiannis

  67. Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment

    Article • Journal of Viral Hepatitis, May 2002, Wiley

    Professor Peter Karayiannis

  68. Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene

    Article • Journal of Hepatology, February 2002, Elsevier

    Professor Peter Karayiannis

  69. Reactivation of precore variant hepatitis B virus in a child with severe aplastic anaemia

    Article • Journal of Medical Virology, November 2001, Wiley

    Professor Peter Karayiannis

  70. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis

    Article • Journal of Hepatology, July 2001, Elsevier

    Professor Peter Karayiannis

  71. Purification of woodchuck hepatitis surface antigen using a monoclonal antibody raised against the antigen

    Article • Journal of Virological Methods, April 2001, Elsevier

    Professor Peter Karayiannis

  72. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient

    Article • Journal of Viral Hepatitis, March 2001, Wiley

    Professor Peter Karayiannis

  73. Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers

    Article • Journal of Medical Virology, January 2001, Wiley

    Professor Peter Karayiannis

  74. Reactivation of precore variant hepatitis B virus in a child with severe aplastic anaemia

    Article • Journal of Medical Virology, January 2001, Wiley

    Professor Peter Karayiannis

  75. Effect of variation in the common ?a? determinant on the antigenicity of hepatitis B surface antigen

    Article • Journal of Medical Virology, February 2000, Wiley

    Professor Peter Karayiannis

  76. Molecular epidemiology gives insight of the routes of transmission of HBV in the gambia

    Article • Journal of Hepatology, January 2000, Elsevier

    Professor Peter Karayiannis

  77. Hepatitis G virus/GBV‐C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes

    Article • Journal of Viral Hepatitis, May 1999, Wiley

    Professor Peter Karayiannis

  78. Severe exacerbation of liver disease during pregnancy in a thalassemic GBV‐C/HGV–positive patient and neonatal hepatitis in offspring

    Article • Journal of Medical Virology, February 1999, Wiley

    Professor Peter Karayiannis

  79. Severe exacerbation of liver disease during pregnancy in a thalassemic GBV-C/HGV-positive patient and neonatal hepatitis in offspring

    Article • Journal of Medical Virology, February 1999, Wiley

    Professor Peter Karayiannis

  80. Natural history and molecular biology of hepatitis G virus/GB virus C

    Article • Clinical and Diagnostic Virology, July 1998, Elsevier

    Professor Peter Karayiannis

  81. Hepatitis D virus

    Article • Reviews in Medical Virology, January 1998, Wiley

    Professor Peter Karayiannis

  82. Hepatitis D virus

    Article • Reviews in Medical Virology, January 1998, Wiley

    Professor Peter Karayiannis

  83. Viral and host factors contribute to fulminant hepatitis following infection with the hbeag negative variant

    Article • Journal of Hepatology, January 1998, Elsevier

    Professor Peter Karayiannis

  84. Epitope mapping of the ‘A’ determinant region of HBV variants reveal marked changes: implications for design of assays for diagnosis of HBV infection

    Article • Journal of Hepatology, January 1998, Elsevier

    Professor Peter Karayiannis

  85. Hepatitis G virus does not cause significant liver disease after liver transplantation

    Article • Journal of Viral Hepatitis, January 1998, Wiley

    Professor Peter Karayiannis

  86. The precore sequence of hepatitis B virus is required for nuclear localization of the core protein

    Article • Hepatology, November 1997, Wiley

    Professor Peter Karayiannis

  87. Identification, prevalence and aspects of molecular biology of hepatitis G virus

    Article • Journal of Viral Hepatitis, September 1997, Wiley

    Professor Peter Karayiannis

  88. Current Status of Hepatitis G Virus (GBV-C) in Transfusion: Is It Relevant?

    Article • Vox Sanguinis, August 1997, Wiley

    Professor Peter Karayiannis

  89. Mapping of the cellular immune responses to woodchuck hepatitis core antigen epitopes in chronically infected woodchucks

    Article • Journal of Medical Virology, June 1997, Wiley

    Professor Peter Karayiannis

  90. Predicted secondary structure of the hepatitis G virus and GB virus-A 5' untranslated regions consistent with an internal ribosome entry site

    Article • Journal of Viral Hepatitis, May 1997, Wiley

    Professor Peter Karayiannis

  91. Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species

    Article • Journal of Hepatology, April 1997, Elsevier

    Professor Peter Karayiannis

  92. Hepatitis G virus: identification, prevalence and unanswered questions.

    Article • Gut, March 1997, BMJ

    Professor Peter Karayiannis

  93. Hepatitis G virus infection

    Article • The Lancet, March 1997, Elsevier

    Professor Peter Karayiannis

  94. Hepatitis G virus infection: clinical characteristics and response to interferon

    Article • Journal of Viral Hepatitis, January 1997, Wiley

    Professor Peter Karayiannis

  95. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease

    Article • Journal of Viral Hepatitis, November 1996, Wiley

    Professor Peter Karayiannis

  96. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

    Article • Journal of Viral Hepatitis, July 1996, Wiley

    Professor Peter Karayiannis

  97. Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicity

    Article • Journal of Viral Hepatitis, July 1996, Wiley

    Professor Peter Karayiannis

  98. The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infection

    Article • Journal of Viral Hepatitis, March 1996, Wiley

    Professor Peter Karayiannis

  99. Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Article • Science, January 1996, American Association for the Advancement of Science

    Professor Peter Karayiannis

  100. Fulminant hepatitis associated with hepatitis B virus e antigen–negative infection: Importance of host factors

    Article • Hepatology, December 1995, Wiley

    Professor Peter Karayiannis

  101. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: Importance of host factors*1, *2

    Article • Hepatology, December 1995, Elsevier

    Professor Peter Karayiannis

  102. The GB hepatitis viruses

    Article • Journal of Viral Hepatitis, September 1995, Wiley

    Professor Peter Karayiannis

  103. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant

    Article • Journal of Hepatology, April 1995, Elsevier

    Professor Peter Karayiannis

  104. A unique insertion in theS gene of surface antigen–negative hepatitis B virus Chinese carriers

    Article • Hepatology, February 1995, Wiley

    Professor Peter Karayiannis

  105. Studies of Cytotoxic T Lymphocyte Activity in Tamarins with Acute Hepatitis A Virus Infection

    Article • January 1994, Springer Science + Business Media

    Professor Peter Karayiannis

  106. Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus

    Article • Journal of Medical Virology, November 1993, Wiley

    Professor Peter Karayiannis

  107. Sequential sequencing studies of the pre-core/core region in a fulminant hepatitis B virus patient and the scurce

    Article • Hepatology, October 1993, Elsevier

    Professor Peter Karayiannis

  108. Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis

    Article • Digestive Diseases and Sciences, November 1992, Springer Science + Business Media

    Professor Peter Karayiannis

  109. In situ hybridization studies in hepatitis A infection

    Article • Hepatology, September 1992, Wiley

    Professor Peter Karayiannis

  110. Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences

    Article • Transfusion, July 1992, Wiley

    Professor Peter Karayiannis

  111. Effect of cyclosporin-A in woodchucks with chronic hepatitis delta virus infection

    Article • Journal of Medical Virology, April 1992, Wiley

    Professor Peter Karayiannis

  112. Serological response and detection of viraemia in acute hepatitis C virus infection

    Article • Journal of Hepatology, March 1992, Elsevier

    Professor Peter Karayiannis

  113. Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

    Article • Hepatology, February 1992, Wiley

    Professor Peter Karayiannis

  114. Anin situ hybridization, molecular biological and immunohistochemical study of hepatitis delta virus in woodchucks

    Article • Hepatology, September 1991, Wiley

    Professor Peter Karayiannis

  115. A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity

    Article • Journal of General Virology, September 1991, Society for General Microbiology

    Professor Peter Karayiannis

  116. Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon–α

    Article • Journal of Medical Virology, June 1991, Wiley

    Professor Peter Karayiannis

  117. Treatment of hepatitis B virus infection with interferon

    Article • Journal of Hepatology, January 1991, Elsevier

    Professor Peter Karayiannis

  118. Genetic diversity of the putative protease/helicase (NS3) gene of HCV

    Article • Journal of Hepatology, January 1991, Elsevier

    Professor Peter Karayiannis

  119. Genetic diversity, expression and serological responses to the structural region of the hepatitis C virus

    Article • Journal of Hepatology, January 1991, Elsevier

    Professor Peter Karayiannis

  120. Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection

    Article • Hepatology, November 1990, Wiley

    Professor Peter Karayiannis

  121. Hepatitis C Virus Antibodies in Subjects With and Without Liver Disease in the United Kingdom

    Article • QJM, October 1990, Oxford University Press (OUP)

    Professor Peter Karayiannis

  122. Vaccine-induced escape mutant of hepatitis B virus

    Article • The Lancet, August 1990, Elsevier

    Professor Peter Karayiannis

  123. Predictive model of response to therapy with interferon in patients with chronic hepatitis B virus infection: A methodological note

    Article • Hepatology, July 1990, Wiley

    Professor Peter Karayiannis

  124. Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia

    Article • The Lancet, June 1990, Elsevier

    Professor Peter Karayiannis

  125. Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

    Article • Journal of Hepatology, May 1990, Elsevier

    Professor Peter Karayiannis

  126. Protracted alanine aminotransferase levels in tamarins infected with hepatitis A virus

    Article • Journal of Medical Virology, February 1990, Wiley

    Professor Peter Karayiannis

  127. Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors

    Article • Hepatology, November 1989, Wiley

    Professor Peter Karayiannis

  128. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.

    Article • BMJ, September 1989, BMJ

    Professor Peter Karayiannis

  129. MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

    Article • The Lancet, September 1989, Elsevier

    Professor Peter Karayiannis

  130. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

    Article • Gut, August 1989, BMJ

    Professor Peter Karayiannis

  131. Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response.

    Article • Gut, August 1989, BMJ

    Professor Peter Karayiannis

  132. Which patients with chronic hepatitis B will respond to alpha interferon therapy? A statistical analysis of predictive factors

    Article • Journal of Hepatology, July 1989, Elsevier

    Professor Peter Karayiannis

  133. Immune response of patients with congenital coagulation disorders to hepatitis b vaccine: Suboptimal response and human immunodeficiency virus infection

    Article • Journal of Medical Virology, June 1989, Wiley

    Professor Peter Karayiannis

  134. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia

    Article • British Journal of Haematology, June 1989, Wiley

    Professor Peter Karayiannis

  135. Pre-S proteins in hepatitis b

    Article • Journal of Medical Virology, May 1989, Wiley

    Professor Peter Karayiannis

  136. Studies of GB hepatitis agent in tamarins

    Article • Hepatology, February 1989, Wiley

    Professor Peter Karayiannis

  137. Point mutations in the pre-core region of HBV in anti-HBe positive patients with chronic hepatitis and persistent HBV replication

    Article • Journal of Hepatology, January 1989, Elsevier

    Professor Peter Karayiannis

  138. A randomised controlled trial of interferon alfa 2A for the treatment of chronic hepatitis B virus infection: Factor, that influence response

    Article • Journal of Hepatology, January 1989, Elsevier

    Professor Peter Karayiannis

  139. Acute and chronic hepatitis delta virus infection: Direct or indirect effect on hepatitis B virus replication?

    Article • Journal of Medical Virology, November 1988, Wiley

    Professor Peter Karayiannis

  140. Non-invasive investigation of liver disease in haemophilic patients.

    Article • Journal of Clinical Pathology, October 1988, BMJ

    Professor Peter Karayiannis

  141. A Preliminary Study of Hepatitis B Virus Replication during Short-Term (7-Day) Social Drinking

    Article • Alcoholism Clinical and Experimental Research, December 1987, Wiley

    Professor Peter Karayiannis

  142. Use of biotinylated probes in serum hepatitis B virus DNA detection

    Article • Journal of Virological Methods, July 1987, Elsevier

    Professor Peter Karayiannis

  143. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferon

    Article • Hepatology, July 1987, Wiley

    Professor Peter Karayiannis

  144. Lymphoblastoid interferon therapy of chronic HBV infection

    Article • Journal of Hepatology, January 1987, Elsevier

    Professor Peter Karayiannis

  145. Perinatal transmission of hepatitis B virus in Kenya: Its relation to the presence of serum HBV-DNA and Anti-HBe in the mother

    Article • Journal of Medical Virology, June 1986, Wiley

    Professor Peter Karayiannis

  146. Hepatitis A virus replication in tamarins and host immune response in relation to pathogenesis of liver cell damage

    Article • Journal of Medical Virology, March 1986, Wiley

    Professor Peter Karayiannis

  147. TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW

    Article • The Lancet, February 1986, Elsevier

    Professor Peter Karayiannis

  148. Chronic hepatitis B virus infection

    Article • Journal of Hepatology, January 1986, Elsevier

    Professor Peter Karayiannis

  149. A pilot study of BW A515U (6-deoxyacyclovir) in chronic hepatitis B virus infection

    Article • Journal of Hepatology, January 1986, Elsevier

    Professor Peter Karayiannis

  150. Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation

    Article • Journal of Hepatology, January 1986, Elsevier

    Professor Peter Karayiannis

  151. A randomized study of the effects of adenine arabinoside 5′-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication

    Article • Hepatology, November 1985, Wiley

    Professor Peter Karayiannis

  152. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen

    Article • BMJ, August 1985, BMJ

    Professor Peter Karayiannis

  153. Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease

    Article • Journal of Medical Virology, August 1985, Wiley

    Professor Peter Karayiannis

  154. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

    Article • Gut, July 1985, BMJ

    Professor Peter Karayiannis

  155. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin

    Article • British Journal of Haematology, July 1985, Wiley

    Professor Peter Karayiannis

  156. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen.

    Article • BMJ, June 1985, BMJ

    Professor Peter Karayiannis

  157. Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate.

    Article • Gut, June 1985, BMJ

    Professor Peter Karayiannis

  158. Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum

    Article • Hepatology, May 1985, Wiley

    Professor Peter Karayiannis

  159. Clinical uses of HBV-DNA assays

    Article • Journal of Virological Methods, April 1985, Elsevier

    Professor Peter Karayiannis

  160. Clinical evaluation of a monoclonal assay for hepatitis B surface antigen:Identification of “HBsAg-like” polypeptides non-reactive in conventional radioimmunoassays

    Article • Journal of Medical Virology, March 1985, Wiley

    Professor Peter Karayiannis

  161. Detection of serum HBV-DNA by molecular hybridisation

    Article • Journal of Hepatology, January 1985, Elsevier

    Professor Peter Karayiannis

  162. Interactions between hepatotropic viruses in patients with haemophilia

    Article • Journal of Hepatology, January 1985, Elsevier

    Professor Peter Karayiannis

  163. Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease

    Article • Journal of Hepatology, January 1985, Elsevier

    Professor Peter Karayiannis

  164. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.

    Article • Gut, November 1984, BMJ

    Professor Peter Karayiannis

  165. The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyte

    Article • Journal of Medical Virology, January 1984, Wiley

    Professor Peter Karayiannis

  166. Aetiology of acute sporadic hepatitis in adults in kenya

    Article • Journal of Medical Virology, January 1984, Wiley

    Professor Peter Karayiannis

  167. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.

    Article • Gut, November 1983, BMJ

    Professor Peter Karayiannis

  168. Prevalence of a non-A, non-B-associated antigen/antibody system detected by radioimmunoassay in acute and chronic liver disease

    Article • Journal of Medical Virology, January 1983, Wiley

    Professor Peter Karayiannis

  169. Experimental infection of tamarins with human non-a, non-b hepatitis virus

    Article • Journal of Medical Virology, January 1983, Wiley

    Professor Peter Karayiannis

  170. Failure to detect nucleic acid homology between some non-A, Non-B viruses and hepatitis B virus DNA

    Article • Journal of Medical Virology, January 1983, Wiley

    Professor Peter Karayiannis

  171. Persistence of chlamydial infection after treatment for neonatal conjunctivitis.

    Article • Archives of Disease in Childhood, March 1981, BMJ

    Professor Peter Karayiannis

  172. The Role of Calf Serum in the Growth of Chlamydia trachomatis in McCoy Cell Cultures

    Article • Microbiology, January 1981, Society for General Microbiology

    Professor Peter Karayiannis

  173. Quantitative aspects of chlamydial infection of the cervix.

    Article • Sexually Transmitted Infections, June 1980, BMJ

    Professor Peter Karayiannis

  174. Isolation of Chlamydia trachomatis from Bartholin's ducts.

    Article • Sexually Transmitted Infections, December 1978, BMJ

    Professor Peter Karayiannis

  175. Hepatitis B Surface Antigen (HBsAg) Variants

    Article • Wiley

    Professor Peter Karayiannis

  176. Molecular Variations in the Core Promoter, Precore and Core Regions of Hepatitis B Virus, and their Clinical Significance

    Article • Wiley

    Professor Peter Karayiannis